Thousands of people reach retirement age every day, and millions more will turn 65 in the next decade. Many of them, even those who have funded a comfortable retirement, have neglected an estate plan.
CEP certification confirms Brains Bio’s naturally-derived CBD pharmaceutical ingredient meets European Pharmacopoeia standards, providing a significant regulatory advantage for drug developers and ...
Linnea is proud to announce that its Cannabidiol (CBD) Isolate has been granted a Certificate of Suitability to the European Pharmacopoeia (CEP). The CEP serves to attest that the quality of an active ...
The MarketWatch News Department was not involved in the creation of this content. Brains Bioceutical Set to Achieve One of the World's First CEP for Cannabidiol Certification with the European ...
The EDQM grants Gnosis a CEP for teicoplanin, a true fermentation glycopeptide antibiotic produced by actinoplanes teichomyceticus strains. The European Directorate for the Quality of Medicines (EDQM) ...
RIAZZINO, Switzerland, March 03, 2026--(BUSINESS WIRE)--Linnea is proud to announce that its Cannabidiol (CBD) Isolate has been granted a Certificate of Suitability to the European Pharmacopoeia (CEP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results